Diagnostics sales up in local currencies at Roche:
This article was originally published in Clinica
Executive Summary
Diagnostics sales at Roche fell 10% to SwFr 490 million ($434 million) in the first quarter of 1995, compared with the same period last year. However, this masked a 4% rise in diagnostic sales in local currencies. At the end of April, shareholders approved Roche Biomedical Lab's merger with National Health Labs (see Clinica No 653, p 15). Group sales increased 2% in SwFr terms (15% in local currencies) to SwFr 5,075 million in the first quarter compared with the same period last year. This was due mainly to strong growth in pharmaceutical sales.